96
Participants
Start Date
October 12, 2022
Primary Completion Date
November 30, 2024
Study Completion Date
November 30, 2024
all-trans retinoic acid
ATRA 10 mg, 2 times a day, orally.The treatment course is 12 weeks.
Eltrombopag
The initial dose of eltrombopag is 50 mg/time, once a day, and the dose is increased when the platelet count is lower than 5×109/L, the maximum is 75 mg/d, and the dose is higher than 200×109/L. When the drug is temporarily discontinued, the drug is re-administered according to the platelet count.The treatment course is 12 weeks.
Peking University Insititute of Hematology, Peking University People's Hospital, Beijing
Beijing Tongren hospital, Beijing
Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing
Department of Hematology, Beijing Hospital, Beijing
Department of Hematology, Senior Department of Hematology, the Fifth Medical Center of PLA General Hospital, Beijing
Beijing Friendship Hospital
OTHER
Beijing Tongren Hospital
OTHER
Beijing Hospital
OTHER_GOV
Navy General Hospital, Beijing
OTHER
Peking University People's Hospital
OTHER